$443 Million is the total value of Nekton Capital Ltd.'s 18 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 88.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QGEN | Buy | QIAGEN NV | $88,913,073 | +21.7% | 1,782,897 | +0.7% | 20.06% | +0.7% |
| ZBH | Buy | ZIMMER BIOMET HO | $41,007,188 | +37.1% | 321,625 | +12.4% | 9.25% | +13.6% |
| GOOGL | Buy | ALPHABET INC-Acap stk cl a | $40,727,850 | +10.5% | 461,610 | +19.8% | 9.19% | -8.5% |
| HZNP | New | HORIZON THERAPEU | $30,830,127 | – | 270,915 | +100.0% | 6.95% | – |
| Buy | JACOBS SOLUTIONS | $29,546,105 | +37.6% | 246,074 | +24.4% | 6.66% | +14.0% | |
| EA | Sell | ELECTRONIC ARTS | $27,068,002 | -5.6% | 221,542 | -10.6% | 6.11% | -21.9% |
| CME | New | CME GROUP INC | $27,007,337 | – | 160,605 | +100.0% | 6.09% | – |
| SJR | Buy | SHAW COMM-Bcl b conv | $21,726,734 | +19.3% | 754,894 | +0.7% | 4.90% | -1.2% |
| New | BROOKFIELD-A | $19,283,184 | – | 672,591 | +100.0% | 4.35% | – | |
| UDR | New | UDR INC | $18,929,442 | – | 488,754 | +100.0% | 4.27% | – |
| HTHT | New | H WORLD GROU-ADRsponsored ads | $16,855,375 | – | 397,345 | +100.0% | 3.80% | – |
| New | BROOKFIELD CORPcl a ltd vt sh | $16,253,400 | – | 516,637 | +100.0% | 3.67% | – | |
| EXPE | Buy | EXPEDIA GROUP IN | $16,157,207 | -1.5% | 184,443 | +5.4% | 3.64% | -18.4% |
| BMRN | BIOMARIN PHARMAC | $15,795,886 | +22.1% | 152,632 | 0.0% | 3.56% | +1.1% | |
| OTIS | New | OTIS WORLDWI | $14,058,916 | – | 179,529 | +100.0% | 3.17% | – |
| LAC | Buy | LITHIUM AMERICAS | $9,778,598 | +26.3% | 516,021 | +74.8% | 2.21% | +4.6% |
| ALNY | ALNYLAM PHARMACE | $8,053,959 | +18.7% | 33,890 | 0.0% | 1.82% | -1.7% | |
| ALC | New | ALCON INC | $1,342,620 | – | 19,586 | +100.0% | 0.30% | – |
| CNHI | Exit | CNH INDUSTRIAL N | $0 | – | -854,929 | -100.0% | -2.60% | – |
| BAM | Exit | BROOKFIELD ASS-Acl a ltd vt sh | $0 | – | -235,375 | -100.0% | -2.62% | – |
| GM | Exit | GENERAL MTRS CO | $0 | – | -360,000 | -100.0% | -3.15% | – |
| TTWO | Exit | TAKE-TWO INTERAC | $0 | – | -110,888 | -100.0% | -3.29% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -163,275 | -100.0% | -3.59% | – |
| GDDY | Exit | GODADDY INC-Acl a | $0 | – | -189,850 | -100.0% | -3.67% | – |
| GM | Exit | GENERAL MTRS COcall | $0 | – | -1,085,200 | -100.0% | -12.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QIAGEN NV | 8 | Q3 2023 | 20.1% |
| JACOBS SOLUTIONS | 5 | Q3 2023 | 6.8% |
| ZIMMER BIOMET HO | 4 | Q4 2022 | 9.7% |
| CNH INDUSTRIAL N | 4 | Q3 2022 | 13.7% |
| HORIZON THERAPEU | 4 | Q2 2023 | 9.4% |
| TERMINIX GLOBAL | 3 | Q2 2022 | 22.8% |
| UNION PAC CORP | 3 | Q3 2023 | 10.5% |
| EMERSON ELEC CO | 3 | Q3 2023 | 8.7% |
| ALCON INC | 3 | Q2 2023 | 11.4% |
| PTC INC | 3 | Q3 2023 | 8.1% |
View Nekton Capital Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-10 |
View Nekton Capital Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.